Skip to main content
Category

Media Releases

CancerClinical ScienceEmergency MedicineFundingGenetic Neuromuscular DisordersLabMedia ReleasesNews & Events

Big ideas pay off for West Australian researchers

By | Cancer, Clinical Science, Emergency Medicine, Funding, Genetic Neuromuscular Disorders, Lab, Media Releases, News & Events

Harry Perkins Institute of Medical Research recognised by Federal Government for innovative research projects Detection of illicit drugs, novel cancer research, fighting infections in rapid time and hunting for rare…

Cell-To-Cell CommunicationCellsDisease AreaMedia ReleasesNews & EventsResearchResearch AreaStatementsSystems Biology and Genomics

Perkins researcher elected as prestigious new Fellow

By | Cell-To-Cell Communication, Cells, Disease Area, Media Releases, News & Events, Research, Research Area, Statements, Systems Biology and Genomics

Professor Alistair Forrest from the Harry Perkins Institute of Medical Research has been selected alongside 27 new Fellows of the Australian Academy of Health and Medical Sciences. Professor Forrest is…

Epigenetics and Genomics LaboratoryMedia ReleasesMolecular Endocrinology and PharmacologyNews & Events

Dual win sees two Harry Perkins researchers awarded in 2020 Business Events Perth Aspire Awards

By | Epigenetics and Genomics Laboratory, Media Releases, Molecular Endocrinology and Pharmacology, News & Events

Business Events Perth, in partnership with the Harry Perkins Institute of Medical Research, is pleased to announce that the inaugural Harry Perkins Aspire Award has been presented to two applicants:…

Breast CancerBreast CancerCancerCancer EpigeneticsLabMedia ReleasesNews & EventsResearch

Honeybee venom kills breast cancer cells

By | Breast Cancer, Breast Cancer, Cancer, Cancer Epigenetics, Lab, Media Releases, News & Events, Research

Venom from honeybees found to kill aggressive breast cancer cells – Australian research published in Nature Precision Oncology  Honeybee venom induces cancer cell death in hard to treat triple-negative breast cancer with minimal effect on healthy cells. Using…

Back
Close Menu